Senior Director, Head of Insights and Analytics - North America
Sobi
Summary
The Senior Director / Head of North America Insights & Analytics leads the function responsible for converting market, customer, competitive and performance information into decisions for North America in-line and launch products. As a member of the department leadership team, this leader advises senior North America Commercial and cross-functional stakeholders on portfolio strategy, resource allocation, forecasting and execution.
Job description
Key Responsibilities
Portfolio Strategy and Decision Support
- Lead North America portfolio insights and provide evidence-based recommendations for commercial planning, launch readiness and investment prioritization across therapeutic areas and lifecycle stages
- Translate North America performance, market, access and competitive evidence into clear options, trade-offs, risks and recommendations for senior leaders.
- Integrate North America epidemiology, pricing and reimbursement, customer behavior and competitive developments into cohesive strategic perspectives.
Performance Analytics and Forecasting
- Own North America performance reporting and dashboarding, including portfolio and brand performance frameworks, KPI definitions, recurring and ad hoc reports, and executive business reviews.
- Own customer segmentation and targeting strategy, and national and sub-national analytics.
- Connect campaign, channel and promotional-response measurement with brand and portfolio performance, forecasting and decision support.
- Own short- and long-range North America commercial forecasting for in-line and launch products, with transparent assumptions and alignment to North America financial planning, supply planning and launch decisions.
Market, Customer and Access Insights
- Own the North America primary market research and customer insight agenda across HCPs and patients, including qualitative and quantitative research design, execution, synthesis and application.
- Lead the competitive intelligence program, with competitive intelligence focused on commercial competitors and clinical pipeline developments, while integrating relevant regulatory and market access developments and insights from Sales, Marketing and Market Access teams into actionable implications.
- Own and lead the market access analytics capability, which serves as the analytics thought partner for payer, channel and patient access across Sobi’s portfolio, and is responsible for translating complex access, channel and patient journey data into actionable insights.
Department and Cross-Functional Analytics Partnership
- Collaborate with Advanced Analytics team and other Strategic Capabilities and Operations (SCO) teams to support initiatives to guide brand strategy and execution
- Integrate predictive analytics, machine learning and AI-enabled approaches to identify relevant use cases and engage the advanced analytics and AI team when appropriate.
- Partner with the advanced analytics and AI team to shape use cases and evaluate outputs for business relevance, assumptions, limitations and actionability.
- Partner with Data Team to define business requirements for commercial data, reporting and analytics capabilities.
Leadership and Operating Model
- Establish intake, prioritization and stakeholder engagement processes across all directly owned capabilities.
- Own resource allocation, budgets and vendor management across all directly owned capabilities; determine when work should be built internally, purchased or outsourced.
- Pursue novel research methodologies that offer new capabilities and ways to optimize project efficiency
Requirements
- Bachelor's degree in a relevant business, quantitative, life sciences or other related field
- 15+ years of relevant biotechnology, pharmaceutical, life sciences or healthcare experience
- 10+ years in progressively responsible Insights & Analytics leadership roles at Director level or above
- Recent experience building capabilities in a startup, emerging or high-growth life sciences organization
- Deep expertise across several areas, including commercial analytics, segmentation and targeting, HCP and patient market research, North America commercial and launch product forecasting, competitive intelligence, field intelligence and market access analytics
- Working knowledge of advanced analytics and AI-enabled approaches, with demonstrated ability to define business use cases, evaluate outputs and partner effectively with peer technical teams
- Experience supporting North America in-line brands, launches and portfolio decisions in a complex, matrixed environment
- Proven ability to influence senior executives, lead teams, manage budgets and external partners, and communicate complex issues clearly
- Experience with Veeva CRM, Tableau or comparable commercial data, CRM and visualization platforms
- Experience in oncology, hematology, immunology, rare disease and/or orphan-drug markets
- Experience using real-world evidence, patient-level claims and specialty pharmacy data, and integrating promotional-response and ROI outputs produced by partner teams into commercial decisions
- Experience establishing functional standards, governance processes and operating models for Insights & Analytics
- Enterprise mindset; strategic courage; executive communication; analytical judgment; inclusive people leadership; collaboration and influence; agility; operational discipline; and a hands-on builder mentality
- Ability to travel to North America offices in Waltham, Massachusetts and Durham, North Carolina, and to other meetings as business needs require
Benefits
- 401(k) Matching
- Tuition Reimbursement
- Wellness Reimbursement
- Medical, Dental & Vision
- Recognition Awards
- Short-Term Bonus
- Long-Term Bonus
- Generous Time Off
- Work-Life Balance
- Conference Attendance
Company overview
Sobi, officially known as Swedish Orphan Biovitrum AB, is an international specialty biopharmaceutical company headquartered in Stockholm, Sweden, dedicated to transforming the lives of people with rare diseases. The company focuses on developing and commercializing breakthrough therapies in three key therapeutic areas: haematology, immunology, and specialty care. With a strong commitment to rare diseases, Sobi addresses conditions affecting small patient populations that often have limited treatment options. The company's product portfolio includes innovative treatments for haemophilia, immune thrombocytopenia, paroxysmal nocturnal haemoglobinuria, familial Mediterranean fever, cryopyrin-associated periodic syndromes, and respiratory syncytial virus. Listed on Nasdaq Stockholm under the ticker SOBI, Sobi operates globally with approximately 1,600 employees across 32 countries. The company emphasizes patient-centric approaches, strategic partnerships, and sustainable business practices while maintaining a robust pipeline of innovative medicines to address unmet medical needs in rare disease communities worldwide.